Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-009391
Filing Date
2025-03-06
Accepted
2025-03-06 16:16:02
Documents
116
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2848593
2 ex19-1.htm EX-19.1 161765
3 ex21-1.htm EX-21.1 11903
4 ex23-1.htm EX-23.1 4292
5 ex31-1.htm EX-31.1 18995
6 ex31-2.htm EX-31.2 19177
7 ex32-1.htm EX-32.1 7182
8 ex32-2.htm EX-32.2 7311
9 ex19-1_001.jpg GRAPHIC 3087
  Complete submission text file 0001493152-25-009391.txt   10654793

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE xtnt-20241231.xsd EX-101.SCH 61303
11 XBRL CALCULATION FILE xtnt-20241231_cal.xml EX-101.CAL 119919
12 XBRL DEFINITION FILE xtnt-20241231_def.xml EX-101.DEF 246343
13 XBRL LABEL FILE xtnt-20241231_lab.xml EX-101.LAB 549969
14 XBRL PRESENTATION FILE xtnt-20241231_pre.xml EX-101.PRE 456179
120 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1561968
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34951 | Film No.: 25715449
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)